School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
Department of Chemical and Process Engineering, University of Surrey, Guildford, UK.
Int J Nanomedicine. 2017 Dec 13;12:8801-8811. doi: 10.2147/IJN.S149717. eCollection 2017.
Solid self-emulsifying drug delivery system (SSEDDS), which incorporates liquid SEDDS into a solid dosage form, has been recently introduced to improve the oral bioavail-ability of poorly water-soluble drugs. However, supersaturated drug generated by SSEDDS is thermodynamically unstable and tends to precipitate rapidly prior to absorption, resulting in compromised bioavailability. The aim of this study was to construct a novel supersaturated SSEDDS (super-SSEDDS) by combining SSEDDS with appropriate precipitation inhibitor. Fenofibrate (FNB), a sparingly soluble drug, was selected as a model drug in this study. An optimized SSEDDS was prepared by solvent evaporation by using mesoporous silica Santa Barbara Amorphous-15 as the inert carrier. Supersaturation assay was conducted to evaluate the precipitation inhibition capacity of different polymers, and the results showed that Soluplus could retard the FNB precipitation more effectively and sustain a higher apparent concentration for ~120 min. This effect was also clearly observed in the dissolution profiles of FNB from SSEDDS under supersaturated condition. The study of the mechanism suggested that the inhibition effect might be achieved both thermodynamically and kinetically. The area under the concentration-time curve of the super-SSEDDS was 1.4-fold greater than that of SSEDDS in the absence of Soluplus, based on an in vivo pharmacokinetic study conducted in beagle dogs. This study has demonstrated that the approach of combining SSEDDS with Soluplus as a supersaturation stabilizer constitutes a potential tool to improve the absorption of poorly water-soluble drugs.
固体自乳化药物传递系统(SSEDDS)将液体 SEDDS 纳入固体剂型中,最近被引入以提高低水溶性药物的口服生物利用度。然而,SSEDDS 产生的过饱和药物热力学上不稳定,在吸收前往往会迅速沉淀,导致生物利用度降低。本研究的目的是通过将 SSEDDS 与适当的沉淀抑制剂结合来构建新型过饱和 SSEDDS(超 SSEDDS)。非诺贝特(FNB)是一种难溶性药物,被选为该研究的模型药物。通过溶剂蒸发法,使用介孔硅 Santa Barbara Amorphous-15 作为惰性载体,制备了优化的 SSEDDS。过饱和度测定评估了不同聚合物的沉淀抑制能力,结果表明 Soluplus 可以更有效地延缓 FNB 沉淀,并在约 120 分钟内维持更高的表观浓度。在过饱和条件下 SSEDDS 中 FNB 的溶解曲线也明显观察到了这种效果。机制研究表明,这种抑制作用可能是热力学和动力学上实现的。在没有 Soluplus 的情况下,超 SSEDDS 的浓度-时间曲线下面积比 SSEDDS 增加了 1.4 倍,这是在比格犬体内药代动力学研究中得出的结果。本研究表明,将 SSEDDS 与 Soluplus 结合作为过饱和度稳定剂的方法可能是提高低水溶性药物吸收的一种手段。